propranolol

(redirected from Propranolol hcl)
Also found in: Dictionary.
Related to Propranolol hcl: Propranolol hydrochloride

propranolol

 [pro-pran´o-lol]
a beta-adrenergic blocking agent used as the hydrochloride salt in treatment of hypertension, cardiac arrhythmias, and hypertrophic subaortic stenosis, tremors, and inoperable pheochromocytoma, in prophylaxis of migraine, and for reducing the long-term risk of mortality and reinfarction after the acute phase of a myocardial infarction. Administered orally or intravenously.

propranolol

(prō-prăn′ə-lôl′, -lōl′, -lŏl′)
n.
A beta-blocker drug, C16H21NO2, used to treat hypertension, angina pectoris, cardiac arrhythmia, and certain kinds of tremors, and to prevent migraine headaches.

propranolol

Inderal® Cardiology A β-blocker used for A Fib, angina, HTN, PVCs, and 2º protect against acute MI Mechanism Cell membrane stabilizing Contraindications Bronchospasms, left ventricular dysfunction. See β-blocker.

propranolol

A beta-blocker drug used to treat anxiety, MIGRAINE, high blood pressure (HYPERTENSION), ANGINA PECTORIS and heart irregularities (cardiac arrhythmias). The drug is on the WHO official list. Brand names are Beta-Prograne, Inderal and Syprol.

Propranolol (Inderal)

Medication commonly prescribed to treat high blood pressure; is a beta-adrenergic blocker and can also be used to treat irregular heartbeat, heart attack, migraine, and tremors.

miotics

Drugs that constrict the pupil. They may be used in the treatment of glaucoma and accommodative esotropia and, sometimes, after a mydriatic examination. Miotics are either parasympathomimetic (cholinergic-stimulating) drugs which have a direct muscarinic action, such as pilocarpine and carbachol, or anticholinesterase drugs which block the effect of acetylcholinesterase thus letting acetylcholine produce its effect, such as physostigmine, neostigmine, echothiophate and demecarium. There are also some miotics which act by blocking α-or β-adrenergic receptors. For example, dapiprazole and thymoxamine block the α-adrenergic receptors and propranolol blocks the β-adrenergic receptors. See adrenergic receptors; open-angle glaucoma; sphincter pupillae muscle; mydriatic; parasympathomimetic drug.
References in periodicals archive ?
A statistical experimental approach for the development of propranolol HCl gastric floating tablets and its evaluation.
Design and in vitro evaluation of effervescent gastric floating drug delivery systems of propranolol HCl. Invest Clin 2012; 53(1):60-70.
Par's Propranolol HCL ER is the first product of many under development, to emerge from a joint venture partnership established in 2002 with Nortec Development Associates, Inc., an innovator in the development of controlled release process technologies.
"Propranolol HCl ER makes use of Nortec/Glatt's CPS Technology[R], proprietary drug delivery technology that can be used in the development and manufacture of drug products with controlled release properties," said Eric M.
Propranolol HCl was provided by Dr Reddy's Laboratories Ltd (Hyderabad, India).
Propranolol HCl was geometrically mixed with PEO until a homogeneous blend was achieved.
The release of propranolol HCl from floating tablets was determined by using a Dissolution Tester USP XXIII (LAB-INDIA, Disso 200).
It was observed that all the formulations of propranolol HCl prepared using selected polymers PEO WSR N-60K and PEO WSR 303 complied with compendia standard for uniformity of weight.
In batch P1, propranolol HCl tablets were prepared using PEO WSR N 60K at 1:0.5 ratio of drug: polymer.
PEO WSR 303 was selected as a suitable polymer for the development of gastric effervescent floating tablets of propranolol HCl with low polymer concentration.
According to Eric Mittleberg, executive vice president of pharmaceutical research and development, the propranolol HCl ER capsule is difficult to develop and is being made available to patients as a generic for the first time.